Central and Peripheral Administration of Fibroblast Growth Factor 1 Improves Pancreatic Islet Insulin Secretion in Diabetic Mouse Models

Fibroblast growth factor 1 (FGF1) has been shown to reverse hyperglycemia in diabetic rodent models through peripheral and central administration routes. Previous studies demonstrated that insulin is required for central and peripheral FGF1 metabolic improvements; however, it is unknown if FGF1 targ...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetes
Главные авторы: Tennant, Katherine G., Lindsley, Sarah R., Kirigiti, Melissa A., True, Cadence, Kievit, Paul
Формат: Artigo
Язык:Inglês
Опубликовано: American Diabetes Association 2019
Предметы:
Islet Studies
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6609981/
https://ncbi.nlm.nih.gov/pubmed/31048370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db18-1175
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы